Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Issues in Huntington's disease testing

D C Rubinsztein1, D E Barton, M A Ferguson-Smith

  • 1East Anglian Regional Genetics Service Molecular Genetics Laboratory, Addenbrookes's NHS Trust, Cambridge, UK.

The Quarterly Journal of Medicine
|February 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

2024 VCP International Conference: Exploring multi-disciplinary approaches from basic science of valosin containing protein, an AAA+ ATPase protein, to the therapeutic advancement for VCP-associated multisystem proteinopathy.

Neurobiology of disease·2025
Same author

Yoshinori Ohsumi's Nobel Prize for mechanisms of autophagy: from basic yeast biology to therapeutic potential.

The journal of the Royal College of Physicians of Edinburgh·2017
Same author

Fluorescence-Based Assays to Analyse Phosphatidylinositol 5-Phosphate in Autophagy.

Methods in enzymology·2017
Same author

Calpain inhibition mediates autophagy-dependent protection against polyglutamine toxicity.

Cell death and differentiation·2014
Same author

Essential versus accessory aspects of cell death: recommendations of the NCCD 2015.

Cell death and differentiation·2014
Same author

Inhibition of autophagy, lysosome and VCP function impairs stress granule assembly.

Cell death and differentiation·2014
Same journal

Megaloblastic anaemia of pregnancy and the puerperium; a review of forty-five cases with special reference to their response to treatment.

The Quarterly journal of medicine·2014
Same journal

Carcinoma of the bronchus; a clinical and pathological survey of 866 cases.

The Quarterly journal of medicine·2014
Same journal

Heart failure in acute nephritis.

The Quarterly journal of medicine·2014
Same journal

Uraemia complicating low salt treatment of heart failure.

The Quarterly journal of medicine·2014
Same journal

The effect of tobacco on lung-volume.

The Quarterly journal of medicine·2014
Same journal

Chronic monocytic leukaemia.

The Quarterly journal of medicine·2014
See all related articles

Huntington's disease is linked to an unstable CAG repeat expansion in a specific gene. Rapid PCR tests can measure this, aiding diagnosis, but require careful interpretation due to undetermined accuracy.

Area of Science:

  • Genetics
  • Molecular Biology
  • Neurology

Background:

  • Huntington's disease (HD) is a neurodegenerative disorder.
  • A mutation in the HD gene involves an unstable polymorphic (CAG)n tract.
  • This CAG repeat is abnormally expanded in individuals with Huntington's disease.

Purpose of the Study:

  • To evaluate the utility of Polymerase Chain Reaction (PCR) tests for measuring CAG repeat numbers in Huntington's disease.
  • To discuss the implications of CAG repeat expansion size on age of onset prediction.
  • To advocate for the continued availability of prenatal exclusion testing for Huntington's disease.

Main Methods:

  • Utilizing rapid Polymerase Chain Reaction (PCR) assays to quantify the (CAG)n repeat length in the Huntington's disease gene.

Related Experiment Videos

  • Analyzing the correlation between CAG repeat size and clinical parameters, including age of onset.
  • Reviewing diagnostic protocols and ethical considerations for genetic testing.

    • Main Results:

    • The (CAG)n tract in the Huntington's disease gene is polymorphic, unstable, and expands in affected individuals.
    • Rapid PCR tests offer a potential clinical tool for assessing CAG repeat numbers.
    • The specificity and sensitivity of these PCR tests require further validation.
    • CAG repeat expansion size may correlate with age of onset in cases with over 50 repeats.

    Conclusions:

    • CAG repeat expansion measurement via PCR is a valuable diagnostic approach for Huntington's disease.
    • Clinical application of PCR-based CAG repeat testing necessitates caution regarding test accuracy.
    • Prenatal exclusion testing remains an important option for families affected by Huntington's disease.